- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05555381
Anxiety, Stress and Sleep Problems in People With Early Onset Dementia (Young-D)
September 23, 2022 updated by: Julie Vanderlinden, KU Leuven
The aim of this study is to
- detect and assess needs of people with early onset dementia regarding anxiety, stress and sleep
- implement a 6 week intervention pilot study in wich weekly (hourly) sessions are implemented in day care settings in order to decrease anxiety, stress and sleep problems in people with early onset dementia
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
- needs detection by means of survey and interviews
- implementation of a 6 week program in day care facilities
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Flanders
-
Brussel, Flanders, Belgium, 1000
- Odisee University of Applied Sciences
-
Contact:
- Julie Vanderlinden, phd
- Phone Number: +3253727170
- Email: julie.vanderlinden@odisee.be
-
-
Oost-Vlaanderen
-
Gent, Oost-Vlaanderen, Belgium, 9000
- Familiezorg Oost Vlaanderen
-
Contact:
- Julie Vanderlinden
- Phone Number: 0478916956
- Email: julie.vanderlinden@odisee.be
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- diagnosed with early onset dementia before age of 65Y
Exclusion Criteria:
- severe dementia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group (pilot study)
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
anxiety (GAD7 validated questionnaire)
Time Frame: 6 weeks
|
this is a subjective survey that measures the level of anxiety in daily life.
It is a score of 7 items with a min of 0 and a max of 21.
A higher score indicates a higher anxiety.
|
6 weeks
|
|
stress (perceived stress scale, PSS, validated questionnaire)
Time Frame: 6 weeks
|
this is a subjective survey that measures the level of stress in daily life.
It is a score of 10 items with a min of 0 and a max of 40.
A higher score indicates a higher stress level.
|
6 weeks
|
|
sleep (Insomnia severity index, ISI, validated questionnaire)
Time Frame: 6 weeks
|
this is a subjective survey that measures the level of insomnia.
It is a score of 7 items with a min of 0 and a max of 28.
A higher score indicates a worse level of insomnia
|
6 weeks
|
|
sleep (actigraph)
Time Frame: 6 weeks
|
this is an objective measurement that measures the sleep quantity
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
emotional well being (WEMWBS, Warwick emotional mental wellbeing scale)
Time Frame: 6 weeks
|
this is a subjective survey that measures the level of emotional well being in daily life.
It is a score of14 items with a min of 0 and a max of 77.
A higher score indicates a better wellbeing.
|
6 weeks
|
|
quality of life (QoL) (quality of life in dementia, QUALIDEM)
Time Frame: 6 weeks
|
this is a subjective survey that measures the level of QoL in daily life.
It is a score of 40 items with a min of 0 and a max of 160.
Per (7) subscales the scores are cumulated.
|
6 weeks
|
|
heart rate variance (HRV)
Time Frame: 6 weeks
|
this is an objective measurement that measures level of HRV in daily life, using (non-invasive photoplethysmography)
|
6 weeks
|
|
Depression (Patient Health Questionnaire PHQ-9, validated questionnaire)
Time Frame: 6 weeks
|
this is a subjective survey that measures the level of depression in daily life.
It is a score of 10 items with a min of 0 and a max of 27.
A higher score indicates a more severe level of depression
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Julie Vanderlinden, PhD, Odisee University of Applied Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
November 1, 2022
Primary Completion (Anticipated)
September 30, 2024
Study Completion (Anticipated)
September 30, 2025
Study Registration Dates
First Submitted
June 2, 2022
First Submitted That Met QC Criteria
September 23, 2022
First Posted (Actual)
September 26, 2022
Study Record Updates
Last Update Posted (Actual)
September 26, 2022
Last Update Submitted That Met QC Criteria
September 23, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Young-D
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Center for Advanced Facial Plastic SurgeryCompletedStress | Stress, Physiological | Stress Response | Stress (Psychology) | Healthy Adult Female Participants | Stress, Psychologic | Stress Perception | Stress Levels | Stress, Psychological CumulativeUnited States
-
Amsterdam UMC, location VUmcRigshospitalet, Denmark; Universitätsklinikum Hamburg-EppendorfNot yet recruitingStress | Stress and Burnout | Stress BiomarkersGermany, Denmark
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...CompletedStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Canterbury Christ Church UniversitySussex Partnership NHS Foundation TrustEnrolling by invitationOccupational Stress or Workplace StressUnited Kingdom
-
University of PadovaCompletedStress | Stress Disorder | Work Related StressItaly
-
Amasya UniversityCompletedThe Effect of Online Stress Management Program on Nurses' Individual Workload Perception, and StressStress | Nursing | Stress ManagementTurkey (Türkiye)
-
University of Thi-QarCompletedPsychological Stress | Academic StressIraq
-
University of North Carolina, Chapel HillWashington University School of Medicine; United States Department of Defense; University of Florida and other collaboratorsRecruitingPost-traumatic Stress Disorder | Acute Stress Disorder | Acute Stress ReactionUnited States
-
K.G. Razumovsky Moscow State University of Technologies...RecruitingStress | Stress (Psychology)Russia
Clinical Trials on young-D program
-
Tel Hai CollegeEnrolling by invitation
-
Tel Hai CollegeEnrolling by invitation
-
University of Sao PauloUnknownChild DevelopmentBrazil
-
Tel Hai CollegeEnrolling by invitationPrimary PreventionIsrael
-
Tel Hai CollegeCompleted
-
University of Sao PauloUnknownChild DevelopmentBrazil
-
Kaiser PermanenteNational Cancer Institute (NCI)Not yet recruitingSarcoma | Cervical Cancer | Breast Cancer | Ovarian Cancer | Endometrial Cancer | Thyroid Cancer | Testicular Cancer | Melanoma (Skin Cancer) | Colon Rectal Cancer
-
Boston UniversityNational Institute of Mental Health (NIMH)Completed
-
Seoul National University HospitalCompletedAutism Spectrum Disorder | Autism
-
American University of Beirut Medical CenterWorld Vision; Ministry of Public Health, LebanonCompletedChild DevelopmentLebanon